New Brain Target Could Change Alzheimer's Treatment

Swiss scientists have uncovered a new brain target in Alzheimer’s disease: an inactive form of the protein GRK2, which clumps inside nerve cells, sabotages mitochondria, and fuels amyloid buildup. Their breakthrough drug, Compound 10, blocks these harmful clumps, slowing nerve cell loss in mice, reducing Alzheimer’s markers, and even boosting heart health and delaying gray hair. After nearly 20 years of research, the team has patented the compound and is now seeking partners to advance it toward human trials — offering a fresh, potentially game-changing approach to treating Alzheimer’s. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/44ccbeac6e23f2b8